We are live on ! Find out more
FHTX icon

Foghorn Therapeutics

105 hedge funds and large institutions have $212M invested in Foghorn Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

90% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 21

13% more funds holding

Funds holding: 93105 (+12)

1.66% more ownership

Funds ownership: 74.05%75.71% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

6% less capital invested

Capital invested by funds: $226M → $212M (-$13.7M)

Holders
105
Holders Change
+12
Holders Change %
+12.9%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
40
Reduced
21
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TWD
101
True Wealth Design
Ohio
$96 +$82 +15 +300%
WPA
102
Wealth Preservation Advisors
Tennessee
$62 +$71 +13 New
FFA
103
Farther Finance Advisors
California
$44 +$49 +9 New
Osaic Holdings
104
Osaic Holdings
Arizona
$24 -$5.62K -1,024 -100%
Jane Street
105
Jane Street
New York
-$716K -132,501 Closed
Marshall Wace
106
Marshall Wace
United Kingdom
-$156K -28,893 Closed
Two Sigma Investments
107
Two Sigma Investments
New York
-$89.6K -16,600 Closed
XT
108
XTX Topco
Cayman Islands
-$84.6K -15,662 Closed
IIM
109
INTECH Investment Management
Florida
-$78.7K -14,576 Closed
BHCM
110
Brevan Howard Capital Management
Jersey
-$56.6K -10,486 Closed
Two Sigma Advisers
111
Two Sigma Advisers
New York
-$56.2K -10,400 Closed
BMS
112
Brummer Multi-Strategy
Sweden
-$25.4K -4,708 Closed
AB
113
Amalgamated Bank
New York
-$6K -1,046 Closed
Royal Bank of Canada
114
Royal Bank of Canada
Ontario, Canada
-$5.38K -980 -98%

FHTX Hedge Fund Activity: Q1 2026 in Review

105 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2026, worth a combined $212M — down 6.1% from $226M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FHTX positions and 9 closed out — a net gain of 13 holders — while 40 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $4.09M. The largest seller was Millennium Management, cutting an estimated $983K.

  • 105 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2026, up from 93 in Q4 2025.
  • Funds reported $212M of Foghorn Therapeutics stock for Q1 2026, down 6.1% quarter-over-quarter.
  • 22 funds opened new Foghorn Therapeutics positions in Q1 2026 and 9 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2026 was Deerfield Management, an estimated $4.09M added.
  • The largest Foghorn Therapeutics seller in Q1 2026 was Millennium Management, an estimated $983K sold.

Based on aggregated 13F filings for Q1 2026.